-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
“The Shijiazhuang Science and Technology Lecture Series” Kicks Off at Shijiazhuang Sihua Pharmaceutical Group
Category:
发布时间：2025-07-28
【概要描述】
On July 24, the Shijiazhuang Science and Technology Lecture Series was inaugurated in the auditorium of the R&D Center (Drug Research Institute) of Shijiazhuang Sihua Pharmaceutical Group. Dr. Ho Wing-kei, Assistant Dean of the Li Ka Shing Faculty of Medicine at the University of Hong Kong, delivered a special lecture titled “AI Reshaping the Healthcare Ecosystem: From Precision Medicine to an Educational Revolution” at the invitation of the group. Wu Hengyao, Shi Jianhui, and Sun Lijie, members of the group’s leadership, attended the event.
On July 24, the Shijiazhuang Science and Technology Lecture Series was inaugurated in the auditorium of the R&D Center (Drug Research Institute) of Shijiazhuang Sihua Pharmaceutical Group. Dr. Ho Wing-kei, Assistant Dean of the Li Ka Shing Faculty of Medicine at the University of Hong Kong, delivered a special lecture titled “AI Reshaping the Healthcare Ecosystem: From Precision Medicine to an Educational Revolution.” Wu Hengyao, Shi Jianhui, and Sun Lijie, leaders of the Group, attended the event.
He Yongji is the Director of the Master’s Program in Biomedical Innovation at the Li Ka Shing Faculty of Medicine, The University of Hong Kong, Deputy Director for Teaching Technology (Artificial Intelligence), and an Associate Professor. His research focuses on the development of scalable computational methods, with particular expertise in single-cell omics data analysis, metagenomic data interpretation, and applications of digital health data.
After nearly two hours, the lecture was delivered entirely in English. Drawing on his own research findings and the University of Hong Kong’s Li Ka Shing Faculty of Medicine’s innovative integration of artificial intelligence, big data, and digital health into its medical curriculum, he shared how AI-assisted diagnostic technologies can be implemented through virtual patient simulation programs. The lecture focused on how this technology helps medical students gain a deeper understanding of AI, enhances the precision of clinical decision-making, and strengthens their capacity for data-driven healthcare practice.
The lecture hall was packed, with the audience hanging on every word and breaking into applause again and again. A research and development professional from the group remarked that the session provided a comprehensive overview of the vast potential applications of AI in reshaping the healthcare ecosystem, offering valuable insights and inspiration for the “AI + pharmaceuticals” sector. They expressed hope that these cutting-edge technologies will drive further transformation and deliver exciting breakthroughs in the high-quality development of the biopharmaceutical industry.
Relevant officials from the governments and management committees of all counties (cities and districts), as well as from relevant municipal departments, municipal universities, research institutes, and key enterprises, together with citizen representatives, attended the lecture on site.
According to reports, the “Shijiazhuang Science and Technology Lecture Series” is initiated and organized by the Shijiazhuang Municipal Bureau of Science and Technology. The initiative aims to strengthen the city’s innovation awareness, enhance its innovative capabilities, and foster a high-quality environment for innovative development. Each session focuses on a specific theme, inviting experts and industry leaders from both China and abroad to share cutting-edge experiences, innovative ideas, and frontier knowledge, thereby delivering forward-looking, targeted, and strategic lectures and exchanges that provide conceptual and technological support for advancing the city’s high-quality development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091